Skip to content

A Observational Study for One-stop Hybrid Coronary Revascularization (HCR) in the Treatment of Multivessel Coronary Artery Disease

A Observational Study for One-stop Hybrid Coronary Revascularization (HCR) in the Treatment of Multivessel Coronary Artery Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021117
Enrollment
Unknown
Registered
2019-01-29
Start date
2019-02-11
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Case series:Nil

Sponsors

Beijing Chaoyang Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Unfavorable LAD for PCI (i.e., chronic total occlusion, excessive tortuosity, severely diffuse lesion), unprotected left main coronary artery disease. Non-LAD lesions were technically feasible for PCI with drug eluting stent (DES). Limitations to traditional CABG, such as pre-existing organs dysfunction, heavily calcified proximal aorta or lack of suitable graft conduits.

Exclusion criteria

Exclusion criteria: Left subclavian artery and LIMA stenosis,buried intramyocardial LAD, need for a concomitant operation,overt congestive heart failure, hemodynamic instability, other conditions rendering PCI unsuitable (e.g., fresh thrombus, coronary vessel diameter < 1.5 mm).

Design outcomes

Primary

MeasureTime frame
The incidence of major adverse cardiac or cerebrovascular events (MACCE) during follow-up;

Secondary

MeasureTime frame
All-cause mortality during follow-up;

Countries

China

Contacts

Public ContactPixiong Su

Beijing Chaoyang Hospital affiliated to Capital Medical University

supixiong1130@163.com+86 13910719885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026